Global Ophthalmology Disorders Drug Market Analysis 2015-2019 and Forecast 2020-2025

Global Ophthalmology Disorders Drug Market Analysis 2015-2019 and Forecast 2020-2025

Report Code: KNJ204372 | No. of Pages: 264 | Category: Pharmaceuticals and Healthcare
Publisher: 99Strategy | Date of Publish: Mar-2020
Snapshot
The global Ophthalmology Disorders Drug market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Ophthalmology Disorders Drug by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Oral
Injection
External Use
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Sanofi
Bayer
Bausch + Lomb
Novartis
Usher Syndrome
Takeda Pharmaceutical
Roche
Pfizer
Allergan
Gilead Sciences
Kubota Pharmaceutical
Alkeus Pharmaceuticals
Astellas Pharma
Ferrer Corporate
Amgen Inc
Editas Medicine Inc
ProQR Therapeutics NV
ReNeuron
Amarantus BioScience
Ocugen
ReGenX Biosciences
Sucampo Pharmaceuticals
Orphagen Pharmaceuticals
Okuvision
Second Sight Medical
Acucela
Stealth BioTherapeutics
Sun Pharma Advanced Research Company
AmpliPhi Biosciences
Applied Genetic Technologies
Asklepios BioPharmaceutical
Biovista
Spark Therapeutics
Caladrius Biosciences
Dompe Farmaceutici
Dormant Projects
Grupo Ferrer Internacional
ID Pharma
InFlectis BioScience
Ionis Pharmaceuticals
Ixchel Pharma
Khondrion
Mimetogen Pharmaceuticals
Mitotech
M's Science
Nanovector
SanBio
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Juvenile Macular Degeneration (Stargardt Disease)
Leber Congenital Amaurosis (LCA)
Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
Usher Syndrome
Retinitis Pigmentosa (Retinitis)
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents

1 Industry Overview
1.1 Ophthalmology Disorders Drug Industry
Figure Ophthalmology Disorders Drug Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Ophthalmology Disorders Drug
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Ophthalmology Disorders Drug
1.2.2 Downstream
Table Application Segment of Ophthalmology Disorders Drug
Table Global Ophthalmology Disorders Drug Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Ophthalmology Disorders Drug Market by Type
3.1 By Type
3.1.1 Oral
Table Major Company List of Oral
3.1.2 Injection
Table Major Company List of Injection
3.1.3 External Use
Table Major Company List of External Use
3.2 Market Size
Table Global Ophthalmology Disorders Drug Market 2015-2019, by Type, in USD Million
Figure Global Ophthalmology Disorders Drug Market Growth 2015-2019, by Type, in USD Million
Table Global Ophthalmology Disorders Drug Market 2015-2019, by Type, in Volume
Figure Global Ophthalmology Disorders Drug Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Ophthalmology Disorders Drug Market Forecast 2020-2025, by Type, in USD Million
Table Global Ophthalmology Disorders Drug Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 Sanofi (Company Profile, Sales Data etc.)
4.1.1 Sanofi Profile
Table Sanofi Overview List
4.1.2 Sanofi Products & Services
4.1.3 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Bayer (Company Profile, Sales Data etc.)
4.2.1 Bayer Profile
Table Bayer Overview List
4.2.2 Bayer Products & Services
4.2.3 Bayer Business Operation Conditions
Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Bausch + Lomb (Company Profile, Sales Data etc.)
4.3.1 Bausch + Lomb Profile
Table Bausch + Lomb Overview List
4.3.2 Bausch + Lomb Products & Services
4.3.3 Bausch + Lomb Business Operation Conditions
Table Business Operation of Bausch + Lomb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Novartis (Company Profile, Sales Data etc.)
4.4.1 Novartis Profile
Table Novartis Overview List
4.4.2 Novartis Products & Services
4.4.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Usher Syndrome (Company Profile, Sales Data etc.)
4.5.1 Usher Syndrome Profile
Table Usher Syndrome Overview List
4.5.2 Usher Syndrome Products & Services
4.5.3 Usher Syndrome Business Operation Conditions
Table Business Operation of Usher Syndrome (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Takeda Pharmaceutical (Company Profile, Sales Data etc.)
4.6.1 Takeda Pharmaceutical Profile
Table Takeda Pharmaceutical Overview List
4.6.2 Takeda Pharmaceutical Products & Services
4.6.3 Takeda Pharmaceutical Business Operation Conditions
Table Business Operation of Takeda Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Roche (Company Profile, Sales Data etc.)
4.7.1 Roche Profile
Table Roche Overview List
4.7.2 Roche Products & Services
4.7.3 Roche Business Operation Conditions
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Pfizer (Company Profile, Sales Data etc.)
4.8.1 Pfizer Profile
Table Pfizer Overview List
4.8.2 Pfizer Products & Services
4.8.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Allergan (Company Profile, Sales Data etc.)
4.9.1 Allergan Profile
Table Allergan Overview List
4.9.2 Allergan Products & Services
4.9.3 Allergan Business Operation Conditions
Table Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Gilead Sciences (Company Profile, Sales Data etc.)
4.10.1 Gilead Sciences Profile
Table Gilead Sciences Overview List
4.10.2 Gilead Sciences Products & Services
4.10.3 Gilead Sciences Business Operation Conditions
Table Business Operation of Gilead Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Kubota Pharmaceutical (Company Profile, Sales Data etc.)
4.11.1 Kubota Pharmaceutical Profile
Table Kubota Pharmaceutical Overview List
4.11.2 Kubota Pharmaceutical Products & Services
4.11.3 Kubota Pharmaceutical Business Operation Conditions
Table Business Operation of Kubota Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Alkeus Pharmaceuticals (Company Profile, Sales Data etc.)
4.12.1 Alkeus Pharmaceuticals Profile
Table Alkeus Pharmaceuticals Overview List
4.12.2 Alkeus Pharmaceuticals Products & Services
4.12.3 Alkeus Pharmaceuticals Business Operation Conditions
Table Business Operation of Alkeus Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
4.13 Astellas Pharma (Company Profile, Sales Data etc.)
4.13.1 Astellas Pharma Profile
Table Astellas Pharma Overview List
4.13.2 Astellas Pharma Products & Services
4.13.3 Astellas Pharma Business Operation Conditions
Table Business Operation of Astellas Pharma (Sales Revenue, Cost, Gross Margin)
4.14 Ferrer Corporate (Company Profile, Sales Data etc.)
4.14.1 Ferrer Corporate Profile
Table Ferrer Corporate Overview List
4.14.2 Ferrer Corporate Products & Services
4.14.3 Ferrer Corporate Business Operation Conditions
Table Business Operation of Ferrer Corporate (Sales Revenue, Cost, Gross Margin)
4.15 Amgen Inc (Company Profile, Sales Data etc.)
4.15.1 Amgen Inc Profile
Table Amgen Inc Overview List
4.15.2 Amgen Inc Products & Services
4.15.3 Amgen Inc Business Operation Conditions
Table Business Operation of Amgen Inc (Sales Revenue, Cost, Gross Margin)
4.16 Editas Medicine Inc (Company Profile, Sales Data etc.)
4.16.1 Editas Medicine Inc Profile
Table Editas Medicine Inc Overview List
4.16.2 Editas Medicine Inc Products & Services
4.16.3 Editas Medicine Inc Business Operation Conditions
Table Business Operation of Editas Medicine Inc (Sales Revenue, Cost, Gross Margin)
4.17 ProQR Therapeutics NV (Company Profile, Sales Data etc.)
4.17.1 ProQR Therapeutics NV Profile
Table ProQR Therapeutics NV Overview List
4.17.2 ProQR Therapeutics NV Products & Services
4.17.3 ProQR Therapeutics NV Business Operation Conditions
Table Business Operation of ProQR Therapeutics NV (Sales Revenue, Cost, Gross Margin)
4.18 ReNeuron (Company Profile, Sales Data etc.)
4.18.1 ReNeuron Profile
Table ReNeuron Overview List
4.18.2 ReNeuron Products & Services
4.18.3 ReNeuron Business Operation Conditions
Table Business Operation of ReNeuron (Sales Revenue, Cost, Gross Margin)
4.19 Amarantus BioScience (Company Profile, Sales Data etc.)
4.19.1 Amarantus BioScience Profile
Table Amarantus BioScience Overview List
4.19.2 Amarantus BioScience Products & Services
4.19.3 Amarantus BioScience Business Operation Conditions
Table Business Operation of Amarantus BioScience (Sales Revenue, Cost, Gross Margin)
4.20 Ocugen (Company Profile, Sales Data etc.)
4.20.1 Ocugen Profile
Table Ocugen Overview List
4.20.2 Ocugen Products & Services
4.20.3 Ocugen Business Operation Conditions
Table Business Operation of Ocugen (Sales Revenue, Cost, Gross Margin)
4.21 ReGenX Biosciences (Company Profile, Sales Data etc.)
4.21.1 ReGenX Biosciences Profile
Table ReGenX Biosciences Overview List
4.21.2 ReGenX Biosciences Products & Services
4.21.3 ReGenX Biosciences Business Operation Conditions
Table Business Operation of ReGenX Biosciences (Sales Revenue, Cost, Gross Margin)
4.22 Sucampo Pharmaceuticals (Company Profile, Sales Data etc.)
4.22.1 Sucampo Pharmaceuticals Profile
Table Sucampo Pharmaceuticals Overview List
4.22.2 Sucampo Pharmaceuticals Products & Services
4.22.3 Sucampo Pharmaceuticals Business Operation Conditions
Table Business Operation of Sucampo Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
4.23 Orphagen Pharmaceuticals (Company Profile, Sales Data etc.)
4.23.1 Orphagen Pharmaceuticals Profile
Table Orphagen Pharmaceuticals Overview List
4.23.2 Orphagen Pharmaceuticals Products & Services
4.23.3 Orphagen Pharmaceuticals Business Operation Conditions
Table Business Operation of Orphagen Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
4.24 Okuvision (Company Profile, Sales Data etc.)
4.24.1 Okuvision Profile
Table Okuvision Overview List
4.24.2 Okuvision Products & Services
4.24.3 Okuvision Business Operation Conditions
Table Business Operation of Okuvision (Sales Revenue, Cost, Gross Margin)
4.25 Second Sight Medical (Company Profile, Sales Data etc.)
4.25.1 Second Sight Medical Profile
Table Second Sight Medical Overview List
4.25.2 Second Sight Medical Products & Services
4.25.3 Second Sight Medical Business Operation Conditions
Table Business Operation of Second Sight Medical (Sales Revenue, Cost, Gross Margin)
4.26 Acucela (Company Profile, Sales Data etc.)
4.26.1 Acucela Profile
Table Acucela Overview List
4.26.2 Acucela Products & Services
4.26.3 Acucela Business Operation Conditions
Table Business Operation of Acucela (Sales Revenue, Cost, Gross Margin)
4.27 Stealth BioTherapeutics (Company Profile, Sales Data etc.)
4.27.1 Stealth BioTherapeutics Profile
Table Stealth BioTherapeutics Overview List
4.27.2 Stealth BioTherapeutics Products & Services
4.27.3 Stealth BioTherapeutics Business Operation Conditions
Table Business Operation of Stealth BioTherapeutics (Sales Revenue, Cost, Gross Margin)
4.28 Sun Pharma Advanced Research Company (Company Profile, Sales Data etc.)
4.28.1 Sun Pharma Advanced Research Company Profile
Table Sun Pharma Advanced Research Company Overview List
4.28.2 Sun Pharma Advanced Research Company Products & Services
4.28.3 Sun Pharma Advanced Research Company Business Operation Conditions
Table Business Operation of Sun Pharma Advanced Research Company (Sales Revenue, Cost, Gross Margin)
4.29 AmpliPhi Biosciences (Company Profile, Sales Data etc.)
4.29.1 AmpliPhi Biosciences Profile
Table AmpliPhi Biosciences Overview List
4.29.2 AmpliPhi Biosciences Products & Services
4.29.3 AmpliPhi Biosciences Business Operation Conditions
Table Business Operation of AmpliPhi Biosciences (Sales Revenue, Cost, Gross Margin)
4.30 Applied Genetic Technologies (Company Profile, Sales Data etc.)
4.30.1 Applied Genetic Technologies Profile
Table Applied Genetic Technologies Overview List
4.30.2 Applied Genetic Technologies Products & Services
4.30.3 Applied Genetic Technologies Business Operation Conditions
Table Business Operation of Applied Genetic Technologies (Sales Revenue, Cost, Gross Margin)
4.31 Asklepios BioPharmaceutical (Company Profile, Sales Data etc.)
4.32 Biovista (Company Profile, Sales Data etc.)
4.33 Spark Therapeutics (Company Profile, Sales Data etc.)
4.34 Caladrius Biosciences (Company Profile, Sales Data etc.)
4.35 Dompe Farmaceutici (Company Profile, Sales Data etc.)
4.36 Dormant Projects (Company Profile, Sales Data etc.)
4.37 Grupo Ferrer Internacional (Company Profile, Sales Data etc.)
4.38 ID Pharma (Company Profile, Sales Data etc.)
4.39 InFlectis BioScience (Company Profile, Sales Data etc.)
4.40 Ionis Pharmaceuticals (Company Profile, Sales Data etc.)
4.41 Ixchel Pharma (Company Profile, Sales Data etc.)
4.42 Khondrion (Company Profile, Sales Data etc.)
4.43 Mimetogen Pharmaceuticals (Company Profile, Sales Data etc.)
4.44 Mitotech (Company Profile, Sales Data etc.)
4.45 M's Science (Company Profile, Sales Data etc.)
4.46 Nanovector (Company Profile, Sales Data etc.)
4.47 SanBio (Company Profile, Sales Data etc.)
5 Market Competition
5.1 Company Competition
Table Global Ophthalmology Disorders Drug Sales Revenue 2015-2019, by Company, in USD Million
Table Global Ophthalmology Disorders Drug Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Ophthalmology Disorders Drug Sales Revenue Share in 2019, by Company, in USD Million
Table Global Ophthalmology Disorders Drug Sales Volume 2015-2019, by Company, in Volume
Table Global Ophthalmology Disorders Drug Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Ophthalmology Disorders Drug Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Ophthalmology Disorders Drug Market Concentration, in 2019
Figure Europe Ophthalmology Disorders Drug Market Market Concentration, in 2019
Figure Asia-Pacific Ophthalmology Disorders Drug MMarket Concentration, in 2019
Figure South America Ophthalmology Disorders Drug Market Concentration, in 2019
Figure Middle East & Africa Ophthalmology Disorders Drug Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Juvenile Macular Degeneration (Stargardt Disease)
Figure Ophthalmology Disorders Drug Demand in Juvenile Macular Degeneration (Stargardt Disease), 2015-2019, in USD Million
Figure Ophthalmology Disorders Drug Demand in Juvenile Macular Degeneration (Stargardt Disease), 2015-2019, in Volume
6.1.2 Demand in Leber Congenital Amaurosis (LCA)
Figure Ophthalmology Disorders Drug Demand in Leber Congenital Amaurosis (LCA), 2015-2019, in USD Million
Figure Ophthalmology Disorders Drug Demand in Leber Congenital Amaurosis (LCA), 2015-2019, in Volume
6.1.3 Demand in Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
Figure Ophthalmology Disorders Drug Demand in Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), 2015-2019, in USD Million
Figure Ophthalmology Disorders Drug Demand in Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), 2015-2019, in Volume
6.1.4 Demand in Usher Syndrome
Figure Ophthalmology Disorders Drug Demand in Usher Syndrome, 2015-2019, in USD Million
Figure Ophthalmology Disorders Drug Demand in Usher Syndrome, 2015-2019, in Volume
6.1.5 Demand in Retinitis Pigmentosa (Retinitis)
Figure Ophthalmology Disorders Drug Demand in Retinitis Pigmentosa (Retinitis), 2015-2019, in USD Million
Figure Ophthalmology Disorders Drug Demand in Retinitis Pigmentosa (Retinitis), 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Ophthalmology Disorders Drug Demand Forecast 2020-2025, by Application, in USD Million
Figure Ophthalmology Disorders Drug Market Growth 2020-2025, by Application, in USD Million
Figure Ophthalmology Disorders Drug Market Share in 2025, by Application, in USD Million
Table Ophthalmology Disorders Drug Demand Forecast 2020-2025, by Application, in Volume
Table Ophthalmology Disorders Drug Market Growth 2020-2025, by Application, in Volume
Table Ophthalmology Disorders Drug Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Ophthalmology Disorders Drug Production 2015-2019, by Region, in USD Million
Table Ophthalmology Disorders Drug Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Ophthalmology Disorders Drug Market 2015-2019, by Region, in USD Million
Table Global Ophthalmology Disorders Drug Market Share 2015-2019, by Region, in USD Million
Table Global Ophthalmology Disorders Drug Market 2015-2019, by Region, in Volume
Table Global Ophthalmology Disorders Drug Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Ophthalmology Disorders Drug Market Size and Growth 2015-2019, in USD Million
Figure North America Ophthalmology Disorders Drug Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Ophthalmology Disorders Drug Market Size 2015-2019, by Country, in USD Million
Table North America Ophthalmology Disorders Drug Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Ophthalmology Disorders Drug Market Size and Growth 2015-2019, in USD Million
Figure Europe Ophthalmology Disorders Drug Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Ophthalmology Disorders Drug Market Size 2015-2019, by Country, in USD Million
Table Europe Ophthalmology Disorders Drug Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Ophthalmology Disorders Drug Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Ophthalmology Disorders Drug Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Ophthalmology Disorders Drug Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Ophthalmology Disorders Drug Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Ophthalmology Disorders Drug Market Size and Growth 2015-2019, in USD Million
Figure South America Ophthalmology Disorders Drug Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Ophthalmology Disorders Drug Market Size 2015-2019, by Country, in USD Million
Table South America Ophthalmology Disorders Drug Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Ophthalmology Disorders Drug Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Ophthalmology Disorders Drug Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Ophthalmology Disorders Drug Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Ophthalmology Disorders Drug Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Ophthalmology Disorders Drug Market Forecast 2020-2025, by Region, in USD Million
Table Ophthalmology Disorders Drug Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com